Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT00338546
Other study ID # 2RO1DA01006409
Secondary ID
Status Withdrawn
Phase Phase 1
First received
Last updated

Study information

Verified date January 2019
Source University of Texas Southwestern Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to improve the scientific understanding of the cardiovascular actions of cocaine, in particular the ability of cocaine to increase blood pressure.


Description:

Cocaine abuse has emerged as a major cause of life-threatening cardiovascular emergencies but our understanding of the underlying mechanisms mediating the adverse effects of cocaine is far from complete. Our previous studies in cocaine-naive human subjects have demonstrated that intranasal cocaine acutely stimulates the human cardiovascular system by a novel central mechanism of action.We are currently investigating a central sympatholytic drug,dexmedetomidine, in reversing the sympathomimetic effects (increase in blood pressure, heart rate and coronary vasoconstriction) of intranasal cocaine.This drug may be a new pharmacologic agent in the treatment of acute cocaine intoxication in humans.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date
Est. primary completion date
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Cocaine naive healthy volunteers

Exclusion Criteria:

- Any evidence of cardiopulmonary disease by history or physical examination

- History of hypertension or 24 hour blood pressure averaging >135/85 mmHg

- Any history of substance abuse (other than tobacco)

- Diabetes mellitus or other systemic illness

- Individuals with a history of pseudocholinesterase deficiency

- Pregnancy

Study Design


Related Conditions & MeSH terms

  • Cocaine Induced Sympathoexciation and Vasoconstriction

Intervention

Drug:
Cocaine hydrochloride

Dexmedetomidine

Procedure:
Microneurography

Laser doppler velocimetry


Locations

Country Name City State
United States Univ of Texas Southwestern Medical Center Dallas Texas

Sponsors (2)

Lead Sponsor Collaborator
University of Texas Southwestern Medical Center National Institute on Drug Abuse (NIDA)

Country where clinical trial is conducted

United States, 

References & Publications (1)

Vongpatanasin W, Mansour Y, Chavoshan B, Arbique D, Victor RG. Cocaine stimulates the human cardiovascular system via a central mechanism of action. Circulation. 1999 Aug 3;100(5):497-502. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Blood pressure
Primary Heart rate
Primary Skin sympathetic nerve activity
Primary Skin blood flow
Primary Coronary blood flow
Secondary Sedation status